Insider filing · INSM
John Drayton Wise
Chief Commercial Officer
profile →
Insmed Incorporated
INSM · Healthcare · 136 filings in 24 months
ticker →
John Drayton Wise sold $640K of Insmed Incorporated (INSM)
Executed Feb 6 2025, disclosed Feb 7 2025, 1 day later.
Value, as filed
$640K
7,910 sh × $80.90
Executed
Feb 6 2025
the trade date, as filed
Disclosed
Feb 7 2025
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
JWJohn Drayton Wise (Chief Commercial Officer) filed 2 Form 4 reports in the past 24 months (0 purchases, 2 sales, 1 filed past the two-business-day deadline), most often in Insmed Incorporated (INSM). The largest single filing was $851K of INSM (12,908 sh across 2 lots, as filed), executed Jan 7 2025.
The name
INSMHealthcare · Insmed Incorporated develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan,…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by John Drayton Wise in INSM
INSMSALE
Insmed Incorporated
$851K12,908 sh across 2 lots
Exec Jan 7 2025
Filed Jan 10 2025 · 5:30 PM ET †